Neoadjuvant Endostatin and Chemotherapy for Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: docetaxel and epirubicin|DRUG: docetaxel and epirubicin plus endostatin
Sponsor: Xijing Hospital